(Q40207813)

18 September 2017

title

Inhibitory effect of the polyinosinic-polycytidylic acid/cationic liposome on the progression of murine B16F10 melanoma (English)

1 reference

18 September 2017

Taku Fujimura

1

1 reference

18 September 2017

Satoshi Nakagawa

2

1 reference

18 September 2017

Tomoyuki Ohtani

3

1 reference

18 September 2017

Yumiko Ito

4

1 reference

18 September 2017

Setsuya Aiba

5

1 reference

18 September 2017

language of work or name

English

0 references

publication date

1 December 2006

1 reference

European Journal of Immunology

18 September 2017

published in

1 reference

18 September 2017

volume

36

1 reference

18 September 2017

issue

12

1 reference

18 September 2017

page(s)

3371-3380

1 reference

Treatment of transplanted rat tumours with double-stranded RNA (BRL 5907). I. Influence of systemic and local administration

18 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636053

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636053

Antitumour evaluation of a ribonuclease resistant double-stranded RNA-polyquaternary ammonium complex (BRL 10739).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636053

Subcellular localization of Toll-like receptor 3 in human dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636053

MIP-3alpha transfection into a rodent tumor cell line increases intratumoral dendritic cell infiltration but enhances (facilitates) tumor growth and decreases immunogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636053

Rejection of B16 melanoma induced by expression of a transfected major histocompatibility complex class I gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636053

Ineffectiveness of poly rI:rC on transplanted tumors induced by methylcholanthrene

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636053

7 January 2021

Influence of synthetic double-stranded ribonucleic acid (poly I:C) on SV40 viral oncogenesis and transplant tumor in hamsters.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636053

7 January 2021

Maturation, activation, and protection of dendritic cells induced by double-stranded RNA

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636053

7 January 2021

Toll-like receptor 3 promotes cross-priming to virus-infected cells.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636053

7 January 2021

Cross-priming of CD8+ T cells stimulated by virus-induced type I interferon

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636053

7 January 2021

The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636053

7 January 2021

The role of IFN regulatory factor-3 in the cytotoxic activity of NS-9, a polyinosinic-polycytidylic acid/cationic liposome complex, against tumor cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636053

7 January 2021

Peritumoral CpG oligodeoxynucleotide treatment inhibits tumor growth and metastasis of B16F10 melanoma cells.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636053

7 January 2021

Immunotherapy for melanoma

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636053

7 January 2021

Intratumoral immunotherapy: using the tumour against itself

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636053

7 January 2021

Impaired H-2 expression in B16 melanoma variants

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636053

7 January 2021

Molecular mechanisms used by tumors to escape immune recognition: immunogenetherapy and the cell biology of major histocompatibility complex class I.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636053

7 January 2021

In vitro priming of cytotoxic T lymphocytes against poorly immunogenic epitopes by engineered antigen-presenting cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636053

7 January 2021

Restoration of MHC class I surface expression and endogenous antigen presentation by a molecular chaperone

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636053

7 January 2021

Proliferating dendritic cell progenitors in human blood

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636053

7 January 2021

Dendritic cells differently respond to haptens and irritants by their production of cytokines and expression of co-stimulatory molecules

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636053

7 January 2021

Adoptive tumor therapy with T lymphocytes enriched through an IFN-gamma capture assay.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636053

7 January 2021

Identifiers

DOI

10.1002/EJI.200636053

1 reference

18 September 2017

1 reference